The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
The global burden of liver disease: The major impact of China
Open accessAbstract
Liver disease is a major cause of illness and death worldwide. In China alone, liver diseases, primarily viral hepatitis (predominantly hepatitis B virus [HBV]), nonalcoholic fatty liver disease, and alcoholic liver disease, affect approximately 300 million people. The establishment of the Expanded Program on Immunization in 1992 has resulted in a substantial decline in the number of newly HBV-infected patients; however, the number of patients with alcoholic and nonalcoholic fatty liver diseases is rising at an alarming rate. Liver cancer, one of the most deadly cancers, is the second-most common cancer in China. Approximately 383,000 people die from liver cancer every year in China, which accounts for 51% of the deaths from liver cancer worldwide. Over the past 10 years, China has made some significant efforts to shed its "leader in liver diseases" title by investing large amounts of money in funding research, vaccines, and drug development for liver diseases and by recruiting many Western-trained hepatologists and scientists. Over the last two decades, hepatologists and scientists in China have made significant improvements in liver disease prevention, diagnosis, management, and therapy. They have been very active in liver disease research, as shown by the dramatic increase in the number of publications in Hepatology. Nevertheless, many challenges remain that must be tackled collaboratively. In this review, we discuss the epidemiology and characteristics of liver diseases and liver-related research in China.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Moreau, R., Jalan, R., Gines, P., Pavesi, M., Angeli, P., Cordoba, J., Durand, F., Gustot, T., Saliba, F., Domenicali, M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.042 · Cited by 3,020
Prevalence and Control of Diabetes in Chinese Adults
Xu, Y. (2013) · JAMA · doi:10.1001/jama.2013.168118 · Cited by 2,703
Sarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
Liaw, Y.-F., & Chu, C.-M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60207-5 · Cited by 1,218
Prevalence of the metabolic syndrome and overweight among adults in China
Gu, D., Reynolds, K., Wu, X., Chen, J., Duan, X., Reynolds, R. F., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66375-1 · Cited by 917
Sarin, S. K., Kumar, A., Almeida, J. A., Chawla, Y. K., Fan, S. T., Garg, H., de Silva, H. J., Hamid, S. S., Jalan, R., Komolmit, P., et al. (2009) · Hepatology International · doi:10.1007/s12072-008-9106-x · Cited by 763
Global burden of alcoholic liver diseases
Rehm, J., Samokhvalov, A. V., & Shield, K. D. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.007 · Cited by 740
Acute-on chronic liver failure
Jalan, R., Gines, P., Olson, J. C., Mookerjee, R. P., Moreau, R., Garcia-Tsao, G., Arroyo, V., & Kamath, P. S. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.026 · Cited by 646
Wong, V. W.-S., Chu, W. C.-W., Wong, G. L.-H., Chan, R. S.-M., Chim, A. M.-L., Ong, A., Yeung, D. K.-W., Yiu, K. K.-L., Chu, S. H.-T., Woo, J., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300342 · Cited by 491
Current and Future Therapies for Hepatitis C Virus Infection
Liang, T. J., & Ghany, M. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1213651 · Cited by 490
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
The incidence and mortality of major cancers in China, 2012
Chen, W., Zheng, R., Zeng, H., & Zhang, S. (2016) · Chinese Journal of Cancer · doi:10.1186/s40880-016-0137-8 · Cited by 354
ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review.
Eng, M. Y., Luczak, S. E., & Wall, T. L. (2007) · Europe PMC (PubMed Central) · Cited by 324
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
Fan, J. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12036 · Cited by 247
Self-citationLI, Y. M., FAN, J. G., WANG, B. Y., LU, L. G., SHI, J. P., NIU, J. Q., SHEN, W., & CHINESE ASSOCIATION FOR THE STUDY OF LIVER DISEASE (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2010.00477.x · Cited by 219
Self-citationKwon, H.-J., Won, Y.-S., Park, O., Chang, B., Duryee, M. J., Thiele, G. E., Matsumoto, A., Singh, S., Abdelmegeed, M. A., Song, B.-J., et al. (2014) · Hepatology · doi:10.1002/hep.27036 · Cited by 191
Self-citationJi, C. Y., & Chen, T. J. (2013) · PubMed · doi:10.3967/0895-3988.2013.01.001 · Cited by 189
Fatty liver and the metabolic syndrome among Shanghai adults
FAN, J., ZHU, J., LI, X., CHEN, L., LU, Y., LI, L., DAI, F., LI, F., & CHEN, S. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04058.x · Cited by 186
Self-citationLuo, Z., Li, L., & Ruan, B. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.10.009 · Cited by 176
Ji, Cheng, Ye, et al. (2013) · 生物医学与环境科学:英文版 · Cited by 162
The incidences and mortalities of major cancers in China, 2009
Chen, W., Zheng, R., Zhang, S., Zhao, P., Li, G., Wu, L., & He, J. (2013) · 癌症:英文版 · doi:10.5732/cjc.013.10018 · Cited by 159
Prevention of hepatitis B virus–related hepatocellular carcinoma
Lok, A. S. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.045 · Cited by 158
Increasing trends in central obesity among Chinese adults with normal body mass index, 1993–2009
Du, T., Sun, X., Yin, P., Huo, R., Ni, C., & Yu, X. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-327 · Cited by 124
Wang, M., Wang, G., Shen, F., Chen, G., Pan, Q., & Fan, J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3180-9 · Cited by 107
Self-citationIL28B single nucleotide polymorphisms in the treatment of hepatitis C
Lange, C. M., & Zeuzem, S. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.03.006 · Cited by 102
Causes and Outcomes of Acute Liver Failure in China
Zhao, P., Wang, C., Liu, W., Chen, G., Liu, X., Wang, X., Wang, B., Yu, L., Sun, Y., Liang, X., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080991 · Cited by 78
Wang, Q., Yin, J., Xu, L., Cheng, H., Zhao, X., Xiang, H., Lam, H. S., Mi, J., & Li, M. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-249 · Cited by 77
Association between socioeconomic status and obesity in a Chinese adult population
Xiao, Y., Zhao, N., Wang, H., Zhang, J., He, Q., Su, D., Zhao, M., Wang, L., Zhang, X., Gong, W., et al. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-355 · Cited by 72
Self-citationXiang, Y., Ma, X., Lu, J., Cai, Z., Li, S., Xiang, Y., Guo, H., Hou, Y., Li, Z., Li, Z., et al. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00933.x · Cited by 67
Hepatic Histopathology of Morbid Obesity: Concurrence of Other Forms of Chronic Liver Disease
Liew, P., Lee, W., Lee, Y.-C., Wang, H.-H., Wang, W., & Lin, Y.-C. (2006) · Obesity Surgery · doi:10.1381/096089206779319392 · Cited by 60
Self-citationLiao, X.-W., Ling, Y., Li, X., Han, Y., Zhang, S., Gu, L., Yu, D.-M., Yao, B.-L., Zhang, D., Jin, G.-D., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1703 · Cited by 46
Epidemiology of Alcohol Abuse and Dependence in Rural Chinese Men
Zhou, L., Conner, K. R., Phillips, M. R., Caine, E. D., Xiao, S., Zhang, R., & Gong, Y. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01014.x · Cited by 41
How can acute-on-chronic liver failure be accurately identified?
Wang, F., & Zhang, Z. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.72 · Cited by 25
Self-citation[Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease].
Fan, J., Zhou, Q., & Wo, Q.-H. (2010) · PubMed · doi:10.3760/cma.j.issn.1007-3418.2010.09.008 · Cited by 16
Self-citationHepatitis B virus subgenotype C2 is the most prevalent subgenotype in northeast China
Wang, H., Li, D., Liu, W., et al. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02834.x · Cited by 14
Self-citation
Cited by
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Epidemiological Features of NAFLD From 1999 to 2018 in China
Zhou, J., Zhou, F., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2020) · Hepatology · doi:10.1002/hep.31150 · Cited by 678
Zhou, F., Zhou, J., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30702 · Cited by 582
Therapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
Global liver disease burdens and research trends: Analysis from a Chinese perspective
Xiao, J., Wang, F., Wong, N.-K., He, J., Zhang, R., Sun, R., Xu, Y., Liu, Y., Li, W., Koike, K., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.03.004 · Cited by 547
Self-citation
Metadata
- Authors
- Wang, F., Fan, J., Zhang, Z., Gao, B., & Wang, H.
- Venue
- Hepatology
- Published
- 2014-10-29
- Volume
- 60
- Issue
- 6
- Pages
- 2099-2108
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W1821077834
- Cited by
- 1,261
- References
- 37
- FWCI
- 37.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.